Global Robotic Cardiology Surgery Market – Industry Trends and Forecast to 2031

Robotic Cardiology Surgery Market Analysis and Size

The robotic cardiology surgery market continues to surge with advancements in technology and methods. The latest robotic systems enhance precision and efficiency in complex cardiac procedures, driving market growth. Surgeons increasingly utilize these innovations to improve patient outcomes, reduce recovery times, and address challenging cardiovascular conditions with greater accuracy. This trend underscores a transformative shift towards robotic-assisted interventions in cardiology.                               

The global robotic cardiology surgery market size was valued at USD 587.54 million in 2023, is projected to reach USD 1,584.20 million by 2031, with a CAGR of 13.20% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Robotic cardiology surgery refers to advanced procedures where robotic systems assist cardiologists in performing intricate cardiac surgeries with high precision. These systems use miniaturized instruments controlled by surgeons via computer console, enhancing accuracy and reducing recovery times compared to traditional methods. Robotic technology allows for minimally invasive procedures, reducing risks and improving outcomes for patients undergoing complex heart surgeries.            

Robotic Cardiology Surgery Market Dynamics

Drivers

• Increasing Telemedicine and Remote Surgery

Advances in robotic technology have revolutionized cardiology surgery by enabling telemedicine applications. Expert surgeons can now remotely perform complex procedures using robotic systems, expanding access to specialized care in remote or underserved areas. For instance, a surgeon in a major city can guide and operate a robotic system in a rural hospital, providing high-quality cardiac surgery without patients needing to travel long distances. This capability significantly drives market growth by enhancing accessibility and improving patient outcomes.

• Growing Minimally Invasive Surgery

Minimally invasive robotic surgery in cardiology allows surgeons to perform intricate procedures through small incisions, such as mitral valve repairs or coronary artery bypass grafting. This approach minimizes trauma to the patient's body, leading to faster recovery times and reduced risks of infection and bleeding compared to traditional open-heart surgery. As patients experience quicker healing and fewer complications, the demand for robotic cardiac surgery systems grows, driving market expansion globally.

Opportunities

• Growing Aging Population

As the global population ages, there is a rising need for cardiovascular treatments. Robotic surgery meets this demand by offering precise and effective procedures, appealing to both patients and healthcare providers. For instance, in developed countries such as the United States and Japan, where aging demographics are prominent, the adoption of robotic cardiology surgery has surged. This trend underscores the market's growth as it addresses the specific healthcare needs of an aging population effectively.

• Improved Patient Recovery

The adoption of minimally invasive robotic procedures in cardiology surgery is driving market growth by significantly improving patient recovery times. Compared to traditional open-heart surgeries, these advanced techniques often lead to shorter hospital stays and quicker rehabilitation periods. For instance, studies have shown that patients undergoing robotic-assisted heart surgery generally experience reduced pain and faster return to normal activities, which not only enhances patient outcomes but also increases demand for robotic systems in cardiac care.

Restraints/Challenges

• Risk of Technical Failures

The risk of technical failures in robotic systems during surgeries poses a significant barrier to market growth, as potential malfunctions may compromise patient safety and undermine confidence in the technology's reliability. This concern discourages widespread adoption among healthcare providers and patients. 

• High Cost of Robotic Systems

The high cost of robotic surgery systems limits their adoption in smaller healthcare facilities and developing regions, hindering market expansion. This financial barrier restricts access to advanced surgical technology, potentially disadvantaging patients who could benefit from robotic procedures. 

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In November 2022, MedTech start-up SS Innovations expanded its global presence by acquiring Avra Medical Robotics, a U.S. company specializing in surgical robot devices. This acquisition positions SS Innovations to enhance its capabilities and reach in the healthcare sector, aiming to innovate and improve surgical outcomes worldwide
• In November 2022, Accelus achieved U.S. FDA approval for its Remi Robotic Navigation System software update, enabling robotic-assisted pedicle screw placement in lumbar spine fixation surgeries. This milestone enhances Accelus's mission to advance minimally invasive surgery standards, offering surgeons precise tools for improved patient outcomes in spinal procedures
• In November 2022, Smith+Nephew introduced the JOURNEY II ROX Total Knee Solution, a reverse hybrid construct for total knee arthroplasty. Combining advanced bearing materials and anatomic design with cementless tibia fixation, this innovation aims to optimize surgical efficiency and potentially improve long-term outcomes for patients undergoing knee replacement
• In February 2022, Smith+Nephew launched its CORI Surgical System, a next-generation handheld robotics platform, in Japan. This advancement underscores Smith+Nephew's commitment to technological innovation in surgical robotics, empowering Japanese healthcare providers with advanced tools for precise and efficient orthopedic procedures

Robotic Cardiology Surgery Market Scope

The market is segmented on the basis of product and service, equipment type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Service

• Robotic Systems
• Instruments and Accessories
• Maintenance Services
• System Services

 Equipment Type

• Robot Machines
• Navigation Systems
• Planners and Simulators
• Others

End User

• Hospitals
• Research Centers

Robotic Cardiology Surgery Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product and service, equipment type, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the robotic cardiology surgery market in terms of both market share and revenue, bolstered by flexible regulatory frameworks and increasing adoption of innovative, technologically advanced products. This trend is anticipated to persist throughout the forecast period.

Europe is projected to exhibit the highest growth rate in the robotic cardiology surgery market, driven by expanding healthcare infrastructure and flexible compliance standards. These factors facilitate advancements in robotic surgery, enhancing precision and outcomes in cardiac procedures across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Robotic Cardiology Surgery Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Siemens Medical Solutions USA, Inc. (U.S.)
•  Medical Device Business Services, Inc. (U.S.)
• Intuitive Surgical Operations, Inc. (U.S.)
• Accuray Incorporated. (U.S.)
•  Johnson & Johnson Private Limited (U.S.)
• CAE Inc. (Canada)
• Medtronic (Ireland)
• meerecompany Inc. (South Korea)
• Surgical Science Sweden AB (U.S.)
• Titan Medical Inc. (Canada)
• Asensus Surgical US, Inc. (U.S.)
• Siemens Healthineers AG (Germany)

SKU-50558